Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-03 Option Award | 2025-02-14 4:23 pm | N/A 2035-02-03 | ArriVent BioPharma Inc. | AVBP | Kastenmayer James Paul General Counsel | 102,000 | $0 | 102,000 (Direct) | View |
Ownership | 2024-01-25 8:38 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | Kastenmayer James Paul General Counsel | 0 | $0 | 106,004 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 6:24 pm | N/A 2033-02-22 | Aeglea BioTherapeutics Inc. | AGLE | Kastenmayer James Paul General Counsel | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-08-23 Option Award | 2022-08-25 7:39 pm | N/A 2032-08-22 | Aeglea BioTherapeutics Inc. | AGLE | Kastenmayer James Paul Interim CEO & General Counsel | 130,000 | $0 | 130,000 (Direct) | View |
Ownership | 2022-08-25 7:37 pm | N/A N/A | Aeglea BioTherapeutics Inc. | AGLE | Kastenmayer James Paul Interim CEO & General Counsel | 0 | $0 | 219,000 (Direct) | View |